858-692-3573 info@denovicontx.com

On February 8, 2022, Denovicon Therapeutics Founder & CEO, Scott Bembenek will talk (along with BIOVIA’s Ton van Daelen) at SLAS 2022 about how AI and the use of virtual–real cycles is changing the drug discovery process.